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DYNAMICS OF BIOSCIENCES REGULATION AND 
OPPORTUNITIES FOR BIOSCIENCES INNOVATION IN AFRICA: 
EXPLORING REGULATORY POLICY BROKERING 
 
 
Ann Kingiri1 and Andy Hall2 
 
 
Abstract  
 
Knowledge brokering has been explored in the innovation literature to understand how 
different innovation tasks are organised toward technological development. This paper 
reflects upon the role of different organisations as knowledge brokers in regulatory policy 
processes towards putting biosciences research into use. It identifies a practical function-
based typology that describes four categories of policy brokers who perform different 
tasks, with the potential to impact biosciences regulatory policy change. The paper 
concludes with a brief exploration of how policy can support the different functions of 
regulatory policy brokerage to enhance the translation of biosciences research into use for 
the benefit of the poor. Using regulatory policy-making in Kenya as an example, it 
contributes to growing scholarship that seeks to link knowledge emanating from research 
with policy-making and economic development, particularly in an African context.  
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1. INTRODUCTION 
 
 
The Research into Use (RIU) programme, supported by the UK’s Department for 
International Development (DFID), has been experimenting with how agricultural 
research may be better organised to impact positively on poor communities in different 
countries in Africa and Asia. One outcome of the programme has been the revelation of 
the renewed and revitalised role of innovation brokers or intermediaries in influencing 
significant institutional and organisational innovations in agricultural systems (Hall, 
2010). The findings that are emerging from the RIU experience suggest that brokers 
perform a variety of innovation management tasks. This paper examines one of these 
tasks in detail — that of regulatory policy brokerage. By exploring regulatory policy 
brokerage in the agricultural sector, this discussion paper deals with a major challenge 
facing many development initiatives: that of linking knowledge production, policy-
making and economic development. It focuses on the relatively unexplored new 
biosciences, biotechnology and biopesticides sub-sectors.  
 
It is now widely accepted that agricultural research has fallen short of contributing 
effectively to development and poverty reduction (IAASTD, 2009). This has resulted in 
numerous efforts by development policy analysts and researchers to look for effective 
methodological tools that may help address this stalemate and lead to pro-poor innovation 
through improved innovation capacities. Frameworks that promote a systems approach to 
development, for instance, have revealed that innovation can be triggered by many 
factors that go beyond research knowledge, including policies, technology and markets 
(World Bank, 2006). Insights from such frameworks can further elaborate on the 
influence of actors who position themselves as intermediaries in the innovation system 
(Klerkx & Leeuwis, 2009). This may come about through the way innovation activities 
are organised and articulated, and what sort of influence policy has on ensuing practice.  
 
Biosciences development is now accepted as key in addressing many developmental 
challenges (FAO, 2004, 2010). It is also now understood that for biosciences research to 
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translate into use in order to benefit society, an enabling environment is needed — this 
includes institutions, policy and markets (Fukuda-Parr, 2006). Some important elements 
of the enabling environment include intellectual property rights (IPRs) regimes, 
regulations for input markets (particularly seed and chemicals) and biosafety regulation 
(in the case of transgenic crops). As Fukuda-Parr contends, dealing with these elements 
poses a challenge to biosciences development, considering the organisational, 
institutional and social factors that influence the process. In addition, in the highly 
fragmented field of biosciences research and development, many organisations play 
different intermediary roles, including regulatory processes brokering, which may be seen 
as a minor role couched in other major innovation brokerage roles (see, for example, 
different organisations promoting biotechnology development in www.isaaa.org; 
www.ifpri.org; www.aatf-africa.org; www.nepadbiosafety.net). Arguably, this regulatory 
policy brokering role may be dynamic, determined by the situation, the suitability and the 
capacity of different knowledge brokers to perform certain tasks towards addressing the 
situation at hand. Consequently, this may be viewed as an opportunity for policy 
brokerage towards creating an enabling environment for agricultural innovation in a 
developing country context through: 
 
• Addressing gaps that relate to institutional and regulatory capacities (Bananuka, 
2007) 
• Enhancing and promoting the complementary roles of public and private 
investment, not only in technological capacity development (Hall, 2005) but also 
in regulatory policy-making (Karembu et al., 2010) 
• Fostering knowledge flow through linkages between different actors in the 
agricultural innovation system (Clark, 2002) 
• Reducing the suspicion that exists between biotechnology developers, scientists 
and knowledge users (Kingiri, 2010)  
 
All this suggests that it is crucial to start looking into the new and emerging roles of 
knowledge brokers in regulatory policy in light of the positive impact this may have on 
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innovation policy. This is important because different actors in the innovation process 
have different capacities, skills and resources, all of which need to be harnessed for 
development (Hall, 2005).  
 
Theory predicts that brokering knowledge or innovation includes multiple catalysing and 
intermediary functions, including: forming partnerships, advocacy, capacity building, 
mediating, gathering and disseminating information and knowledge, training and 
facilitation (Klerkx & Leeuwis, 2008; Klerkx et al., 2009a,b; Howells, 2006). These 
functions are, without doubt, important for putting research into use but have not received 
adequate attention empirically in the area of agricultural biosciences. In particular, less 
attention has been paid to dynamics related to controversial biosciences subsystems from 
the perspective of brokerage and how this could foster productive regulatory policy 
change. This is important because governance of biosciences, particularly biotechnology, 
is multifaceted and many interested parties in public and private sectors claim to be 
stakeholders (Harsh, 2005; Fukuda-Parr, 2006; Ayele et al., 2006). For instance, the role 
of “high profile” public-private partnerships in catalysing biotechnology innovation has 
received considerable attention, especially by researchers (Spielman et al., 2006; 
Spielman, 2007; Hall, 2005). In addition, nongovernmental organisations (NGOs) that 
work on biotechnology regulation have been linked to retrogressive “epistemic” 
brokerage (Herring, 2010). This has, at times, fueled major controversies that have 
slowed the translation of biosciences research products into use. Arguably, the regulatory 
policy brokering role that has been played by many organisations has not been given 
adequate research attention from the perspective of its impact on innovation. It is also 
important to understand the practical dynamics that govern the establishment and 
operation of such mechanisms, and how the respective contexts influence the brokering 
function (Hall, 2005).  
 
This paper, therefore, aims to achieve several purposes. Firstly, using case studies of a 
number of organisations, it explores the circumstances that have led to their renewed role 
as regulatory policy brokers. Secondly, through the lens of biosciences regulatory policy 
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process, it explores how these organisations operate in practice and illuminates the 
factors that determine their effectiveness as policy brokers. Thirdly, it asks how policy 
can make better use of these types of organisations in its efforts to get research into use. 
This paper’s research approach is in line with the emerging thesis that focuses on 
emerging agricultural innovation brokers, their unique functions and eventual impact on 
the overall innovation system (see, for example, Klerkx & Leeuwis, 2009; Hall, 2010). 
The embedded empirical analysis is spurred by a number of observations: 
 
• Regulation of biosciences is influenced by political economy of biosciences and 
locality (Wield et al., 2010)  
• Strategic state, non-state and international organisations are known to be agents of 
knowledge transfer for policy change (Stone, 2002). Recently, this role has been 
observed in regulatory policy-making as well (Karembu et al., 2010)  
• There are opportunities/challenges presented by these organisations and the 
dynamics of operations for pro-poor biosciences research in Africa — an area that 
remains largely unexplored (Spielman, 2007).  
 
The paper is structured in as follows: The next section outlines the analytical framework 
for this paper by exploring the brokerage concept as debated theoretically in the 
literature, the research approach and the context for brokerage in biosciences research 
and development. This is followed by a section that draws upon empirical material to 
analyse, discuss and classify the selected cases based on their potential to influence 
regulatory policy change. The paper concludes by drawing empirical lessons for policy 
on realistic strategies that can make better use of such broker organisations in order to get 
research into use. 
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2. CONCEPTUALISATION OF THE TERM ‘POLICY BROKER’ 
 
 
The aim of this paper is to understand how brokering occurs in regulatory policy 
dialogues in a practical sense and to draw lessons on how to stimulate the process of 
translation of bioscience research into use. Brokerage as a concept is not new in the 
innovation literature and different terms have been used to describe its meaning. 
Traditional and emerging organisations undertaking this role have been described 
variously in the literature as innovation brokers, intermediary organisations, systemic 
intermediaries, facilitators of innovation and boundary organisations (Winch & Courtney, 
2007; Klerkx & Leeuwis, 2008a, 2009; Klerkx et al., 2009a, b; Howells, 2006; Guston, 
2001). In biotechnology regulatory debates, the term epistemic broker has been used to 
describe those environmental NGOs that oppose biotechnology development (Herring, 
2010). Winch & Courtney (2007, p. 751) define an innovation broker as “an organisation 
acting as a member of a network [………..], focused on enabling other organisations to 
innovate”. The brokerage concept — and its articulation from an agricultural innovation 
system perspective — has also been extensively discussed by Klerkx et al. (2010) & 
World Bank (2006). One key area of agreement in these debates is the point that 
innovation is a product of intense networking and interactive learning among multiple 
actors who play different complementary roles. This implies that the role of a broker or 
intermediary is about mediation towards strengthening the working and delivery of a 
system as a whole. But, as Howells (2006) observes, brokering may not necessarily be 
the main function of an organisation, which can push its function of an intermediary to a 
secondary role.  
 
Klerkx et al. (2010) & Klerkx et al. (2009a,b) describe different tasks that a brokering 
organisation performs, which include different elements of demand articulation, network 
brokerage, innovation process management and knowledge brokering. Demand 
articulation is important during the emerging phase of a technology when the degree of 
uncertainty is high. It is defined as “an iterative, inherently creative process in which 
stakeholders try to unravel preferences for and address what they perceive as important 
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characteristics of an emerging innovation” (Boon et al., 2008, p. 645). It involves 
diagnosis and analysis of problems and articulation of needs. Network brokerage helps to 
connect the suppliers and users of knowledge in order to address market and system 
failures. Innovation process management involves organising and managing the network.  
 
With this broad understanding of the brokerage concept, policy brokering has been 
applied to pursue the objective of this paper. In relation to biosciences regulation, some 
of the tasks policy brokers undertake include advocacy, lobbying policy-makers for 
policy change, training, information sharing among others (for details see Karembu et al., 
2010; Action Aid, 2004; Kingiri, 2011). The use of the policy brokerage concept is based 
on the understanding that the emergence or setting up of an intermediary organisation 
depends on the prevailing institutional environment (Klerkx et al., 2010). Further, as Van 
der Meulen et al. (2005, cited in Klerkx & Leeuwis, 2009, pp. 851-2) note, “the 
establishment of an intermediary organisation is often contingent on the specific context 
or on typical opportunities and needs within research and innovation sectors.” This 
implies that different organisations may behave and impact policy differently in different 
contexts. 
 
As summarised in Klerkx et al. (2009a, pp. 11-12), the brokerage role is confounded by a 
number of complex challenges that may impact the expected outcome. These include 
tensions over legitimacy and neutrality of brokers, and questions over whether 
stakeholders or clients consider them to be honest in their deliberations. There are also 
issues of ambiguity of functions arising from different organisations articulating multiple 
and sometimes conflicting and competing roles and difficulties in evaluating the impact 
of brokerage functions that may affect sustainability after withdrawal or lack of financial 
backing.  
 
Despite the tensions, the catalytic and facilitation role played by innovation brokers adds 
value through efficacy and harmony in an innovation process. Drawing insights from the 
features and nature of brokering functions discussed here, policy brokerage can serve as a 
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conceptual framework for analysis of related functions that public and private 
organisations undertake in regulatory policy processes. The focus of this paper is the new 
biosciences that are knowledge-intensive and the backdrop of a difficult terrain to 
navigate, given the numerous actors involved in the field. The role of brokerage may be 
critical here and can help complement other advancement and developmental goals. 
Moreover, there is also a need to analyse how the different innovation brokerage tasks 
relate to biosciences development. This is in line with the objective of the Research into 
Use (RIU) programme that seeks to enhance knowledge generation and utilisation for the 
purpose of impacting development and requisite social change in poor communities.  
 
Using selected organisations as case studies, this paper analyses and predicts the sorts of 
roles policy brokering organisations might play relative to the tasks alluded to above and 
draws implications for policy. Drawing on insights discussed this far and for the purpose 
of this paper, the organisations identified as policy brokers are intermediary organisations 
that individually or as a group mediate between the demand side (e.g., farmers, 
government, etc.) and the supply side (research institutes, technology developers, etc.) in 
the regulation of the new biosciences knowledge infrastructure in Kenya, where research 
to support this paper was carried out.  
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3. CONTEXT FOR POLICY BROKERAGE: AN OVERVIEW OF 
BIOTECHNOLOGY REGULATION  
 
 
In the last two decades, milestones in the new biosciences, particularly agricultural 
biotechnologies, have revolutionalised the agriculture sector in developing countries 
(FAO, 2010). However, biotechnology development has since been slow and an 
inadequate regulatory framework has been one of the contributing factors. In Kenya, for 
instance, research efforts in the field date back to the 1990s when transgenic sweet potato 
was first approved for testing in the field, but since then no other product has been 
approved for commercial use. The aforementioned revolution had advanced in tandem 
with regulatory policy developments requisite for management of related biosafety risks 
(Nang’ayo, 2010). This had caused both organisational and institutional changes and re-
alignments in line with the integrated mode of operations that these sciences demand 
(Smith, 2009; Kingiri, 2011).  
 
Triggered by this unprecedented revolution, NGOs started to broaden their roles beyond 
traditional ones to look at biosciences research and innovation (Herring, 2010; Karembu 
et al., 2010; Harsh, 2005). In biotechnology development, Harsh (2008) identifies a 
number of roles that NGOs have started to perform, including helping farmers and the 
public experiment with biotechnologies by facilitating their participation in the public 
understanding of the term and engagement in the development of biotechnologies. 
Consequently, NGOs are considered to be knowledge nodes in the agricultural innovation 
systems around biotechnologies. However, given that biotechnology is a controversial 
science, Harsh (2008) cautions that such roles must be analysed in context and 
contingency. In addition, the moves to establish organisational structures for biosafety 
regulation to manage biotechnology research and development following the Cartagena 
Protocol convention (CBD, 2000) as well as the cost involved and the international and 
political context of the debates all provide a context for intermediary organisations to 
articulate the brokering role prominently as activists. Thus, a variety of brokers have 
recently emerged in response to social, economic and political challenges and 
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opportunities experienced by different actors. They have become strategic channels for 
knowledge and information flow as central policy brokers (see Herring, 2010 for a 
detailed analysis of the function of epistemic brokers in biotechnology revolution). 
Moreover, the evolving policy and institutional environment based on context has a role 
to play in shaping the brokering functions (Klerkx et al., 2010). 
 
Organisations dealing with new biotechnologies tend to take on a brokerage role in three 
overlapping areas: 
 
• Biotechnology projects where they either a) support particular projects as 
partners, sometimes managing multiple actors, including researchers, government 
and donors (Kingiri & Ayele, 2009; see also ISAAA’s brokerage role in virus-
resistant sweet potato and tissue culture banana projects at www.isaaa.org;) or b) 
campaign against biotech projects and prevent their commercialisation by 
lobbying the government and mobilising the public to reject them (Herring, 2010; 
Kingiri, 2011)  
• Biosafety regulation. Many NGOs have influenced the development of regulatory 
frameworks in Africa by getting involved in activities around biotechnology, 
including information dissemination, training and sensitisation of the public, 
journalists, political policy-makers, scientists and regulators. Other organisations 
find themselves directly engaged in lobbying and/or support for the drafting of 
legal regulatory policy documents (for details of this see Karembu et al., 2010; 
Kamau, 2010)   
• Importing GMOs food/feed products. This is a pathway through which various 
organisations start to get involved in the regulation of biotechnology products in 
addition to their other mandates. Examples include the Kenya Biodiversity 
Coalition Network, which has resisted the introduction of unauthorised 
biotechnology products (Sunday Nation, 2008). The Program for Biosafety 
System (PBS) has taken on the role of regulatory capacity building in African 
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countries towards the harmonious implementation of biosafety regulations 
(www.pbs.org).   
 
As alluded to elsewhere, the systems failures slowing biotechnology development are 
linked to the lack of appropriate regulatory frameworks for governance of biotechnology. 
As Ikiara (2004) notes in reference to the failure of transgenic sweet potato in Kenya, 
these governance aspects include the management of biosafety, intellectual property 
rights regime, lack of trust between public and private sectors, and poor coordination 
between the national agricultural research organisations, donor agendas, farmers and 
national and international research collaborators, etc. To enhance better and more 
effective governance, regulatory policy brokers can play a pertinent role in strengthening 
linkages between political policy actors, biotechnology scientists, researchers, civil 
society actors, pro-biotechnology organisations, industry, farmers, consumers and 
regulators. 
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4. METHOD FOR DATA GENERATION AND CASE STUDY 
ANALYSIS 
 
 
The empirical data to support this paper was derived from in-depth analysis of a number 
of organisational cases, all of which have links to the biotechnology and biopesticides 
agricultural sub-sectors. The criterion for selection of these cases was based on the 
organisations’ documented roles in biosciences research and related activities (literature), 
and interviews with stakeholders in the sub-sectors conducted in Kenya between 2007 
and 2011. The interviews focused on the roles of these organisations, including the 
involved scientists in bioscience regulation in Kenya and Africa in general. Guided by 
primary data from interviews and secondary material, these cases were analysed to 
understand the regulatory policy brokerage function of the organisations. The information 
obtained through the analysis further helps in developing a function-based typology. 
Drawing insights from Klerkx & Leeuwis (2009), a number of features have aided this 
endeavour:    
 
• History of the organisation, including its outlook (global versus local)  
• Agenda, including the cluster of activities that relate directly or indirectly to 
regulation and policy orientation with the assumption that a diversified policy 
orientation is likely to have more influence on policy  
• Public trust and support in relation to public engagement  
• The nature of partners/linkages   
• Source and stability of funding  
 
In the context of controversial biosciences — namely biotechnology and biopesticides — 
policy brokers seek to provide solutions to regulatory system failures arising from the 
institutionalisation of new biosciences knowledge infrastructure (Gibbons et al., 1994). 
Consequently, it is important to know how these brokers emerge, operate and eventually 
are embedded in the overall innovation system whose functioning they wish to improve 
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(Klerkx & Leeuwis, 2008b). What follows in the next section is a discussion and analysis 
of the selected case studies. 
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5. CASE STUDIES: ANALYSIS OF SELECTED ORGANISATIONS 
AS POLICY BROKERS  
 
 
Eight organisations were picked as case studies for the purpose of this paper based on 
their policy brokerage role. The results of empirical-based analysis are presented in 
several forms. Firstly, each case is discussed in line with different brokerage functions, 
detailing what this entails for regulatory policy and practice. The effectiveness of each 
organisation as a policy broker is also explored. Secondly, the emerging narrative is 
presented in the form of a table (Table 1) and thirdly, a function-based typology of these 
cases is presented in another table (Table 2).  
 
(i) The International Service for the Acquisition and Application of Agri-biotech 
(ISAAA) Africenter 
ISAAA (www.isaaa.org) is non-profit international NGO that brokers agri-biotechnology 
technology transfer more generally. It is well-known for its consistent annual reports on 
the global status of commercialised biotechnology crops, which are referenced widely in 
relation to progress in biotechnology adoption (Clives, 2009). ISAAA AfriCenter is one 
of the regional networks of ISAAA and was established in 1994 in Zimbabwe, but later 
relocated to the International Livestock Research Institute (ILRI) campus in Nairobi, 
Kenya. Although it has an international orientation covering the whole of Africa, most of 
its activities are confined to Kenya — perhaps because of its location — and 
neighbouring East African countries, with limited activities in a number of other African 
countries.  
 
ISAAA AfriCenter has varying brokering missions. Firstly, it brokers access to 
technologies, genes and protocols owned by the private sector and/or international 
research organisations. It had some success in this role over the clonal tree biotechnology 
programme trust, virus-resistant sweet potato and the tissue culture bananas projects 
(personal communication, 2007; Wambugu, 2001; ISAAA, 2010). Secondly, ISAAA has 
been at the forefront of brokering biosafety regulatory policy development in Kenya 
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(Karembu et al., 2010) and neighbouring African countries through sharing Kenya’s 
experience at conferences, training and visits (personal communication, 2010) and 
organising “seeing is believing” field tours to neighbouring countries, where 
biotechnology products are already commercialised. These tours have largely involved 
politicians, regulators and journalists and were meant to influence the fast approval of 
biosafety policies (Karembu et al., 2010; personal communication, 2007). Specifically, 
ISAAA has been playing a steering role, coordinating the many actors — both in the 
public and private sectors — in the regulatory policy development process. Another way 
ISAAA has brokered the biosafety regulatory process is through outreach and 
communication. This is undertaken through biotechnology information centers (BICs), 
which are sources of free information and education materials on biotechnology released 
regularly to interested parties. In 2000, at the height of the biosafety bill development in 
Kenya, ISAAA (and AATF) brokered the initiation and launch of a biotechnology 
knowledge sharing platform — the Open Forum on Agricultural Biotechnology in Africa 
(OFAB). OFAB brings together stakeholders in biotechnology and enables interactions 
among scientists, journalists, the civil society, industrialists, lawmakers and policy-
makers. ISAAA has since brokered similar platforms in Uganda, Tanzania and Nigeria 
(www.ofabafrica.org/country).  
 
ISAAA is currently engaged in informing the public about biotechnology out of the 
realisation that scientists are poor public communicators. It thus bridges the 
communication gap in the field of biotechnology by training regulators, scientists and 
journalists in appropriate and effective communication skills. To reach out to the general 
public, ISAAA is exploring the use of mass media (radio) as a tool for public awareness 
through a programme that is broadcast in local dialects in Kenya and Burkina Faso 
(personal communication, 2010). By bringing together different stakeholders in the 
Regional Approach to Biotechnology and Biosafety Policy in Eastern and Southern 
Africa (RABESA), ISAAA has brokered a policy outreach initiative that to examine if 
there were any major trade implications if Africa adopted biotechnology products 
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(Paarlberg et al., 2006). This study was intended to influence positive biosafety policy 
developments in Africa.  
 
ISAAA articulates its mission and the wide range of activities largely through an 
extended network of partners at the local, regional and international levels (public and 
private organisations, researchers, multinational companies, donors, seed companies etc.). 
It has several partners in the biotechnology seed industry, mainly in the US and India and 
is mainly funded by US Agency for International Development (USAID), the Rockefeller 
Foundation and Canada’s International Development Research Centre (IDRC), among 
others. At the local level, ISAAA has developed a network of partners to perpetuate its 
biotechnology promotion mission. For instance, at the advent of biotechnology in Kenya 
in 1990s, it partnered with the Kenya Agricultural Research Institute (KARI), Monsanto, 
Danforth Center, US and Roodeplaat Vegetable and Ornamental Plant Institute in South 
Africa to promote a virus-resistant sweet potato project (Harsh, 2005).   
 
ISAAA seems to have both social and environmental policy orientations embedded in its 
technology transfer implementation portfolio. However, its proactive approach to 
biosafety policy development attracted criticism from NGOs, who cited potential bias and 
influence from the biotechnology industry (personal communication, 2008 and 2010). In 
addition, the agenda being pursued by ISAAA may have been construed as being that of 
biotechnology promotion with biosafety policy brokerage roles being a means to achieve 
an end more generally. Although the organisation’s ultimate goal is to impact social 
change through biotechnology innovation, promote safer environment and more 
sustainable agriculture by decreasing dependency on water, pesticides, and fertilisers, the 
undisputed promotional approach may have had a negative impact on intended policy 
outcomes. The fact that the funding agencies also seemed to pursue the same mandate 
may have led to impartiality, credibility and legitimacy challenges. 
 
ISAAA may be perceived to be influential in terms of bringing together key actors 
associated with respective policy innovations. This perception has come about given the 
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organisation’s efforts in projects around brokering, particularly biotechnology promotion 
dating back to the 1990s through its established network of banana tissue culture 
stakeholders. Others factors that have contributed to the organisation’s credibility and 
influence include fairly stable financial support from donors and multinational seed 
companies; strong links with regional bodies promoting common trade interests like the 
Common Market for Eastern and Southern Africa (COMESA) and Program for Biosafety 
Systems (PBS); and a strong communication and awareness programme, particularly its 
Forum for Agricultural Biotechnology (OFAB) that attempts to make the private and 
public sectors and the general public dialogue on matters of biotechnology innovation. In 
Kenya, ISAAA has established a strong link with government agencies through the 
lobbying for the biosafety bill enactment (Karembu, et al., 2010; www.isaaa.org/kc).  
 
(ii) African Agricultural Technology Foundation (AATF)  
AATF (www.aatf-africa.org) is a nonprofit nongovernmental organisation with a regional 
focus. It was launched in Nairobi, Kenya in June 2004 with the aim of increasing 
productivity and use of biotechnology products for the benefit of resource-poor farmers 
in Africa (AATF, 2010). To achieve this objective, it is involved in a variety of brokerage 
activities, which are operationalised during brokerage of intellectual property rights 
(IPRs) currently in the hands of a few players, and making them accessible royalty-free 
for use in activities geared towards benefiting the poor. Thus, AATF plays a catalytic and 
brokerage role, fostering partnerships between the multiple actors involved, while 
articulating the demands and interests of each stakeholder. Examples of projects that 
AATF has been involved in include the Water Efficient Maize for Africa (WEMA) and 
the nutritionally enhanced sorghum varieties (for details of these projects, including 
actors involved, see AATF, 2010).  
 
AATF also brokers regulatory policy development as a means to achieve its 
biotechnology developmental goal. Through its regulatory affairs office, it has been 
supporting biosafety capacity building, gathering and providing information on 
regulatory milestones in the world for the benefit of the African regulatory regime, and 
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has also been involved in public education and awareness. An initiative that fulfills this 
role is the knowledge sharing platform, OFAB, which AATF and ISAAA actively 
brokered. The two organisations have continued to finance monthly meetings (personal 
communication, 2008) of the platform. During the development of Kenya’s biosafety 
legislation, AATF and ISAAA brokered the lobbying of its enactment through proactive 
awareness creation, targeting policy-makers and regulators (Karembu et al., 2010). Due 
to rising resistance from civil society actors, AATF and ISAAA brokered the founding of 
the National Biotechnology Awareness Strategy (BioAWARE) and Kenya Biosafety 
Coalition (KBC) through demand articulation and network formation (for detailed 
accounts of institutionalisation of these initiatives, see Kingiri, 2011). Arguably, these are 
supposed to be government initiatives but these two brokers brought in much needed 
resources — namely technical knowledge, finances, network formation skills and 
lobbying the ministry of agriculture — towards the inclusion of the private sector in 
biotechnology debates (personal communication, 2008; Kingiri, 2011). AATF brokering 
activities are funded by the Rockefeller Foundation, DFID, USAID, the Bill & Melinda 
Gates Foundation and the Howard Buffett foundation. Debatably, some of these entities 
are perceived locally as promoting new biotechnology innovations, which may have 
affected the credibility and neutrality of AATF and ISAAA as policy brokers.  
 
The activities of AATF are oriented towards social change through poverty reduction, but 
the effects of these activities are yet to be seen, as most of the projects in the pipeline are 
still under research and development. The potential to broker knowledge that is currently 
unavailable to many developing nations and making it available to researchers and the 
resource-poor all are strong factors for negotiating and influencing policy change. In 
addition, the fostering of partnerships (networks formation skills) has meant that AATF 
has had a significant influence on institutional change linked to technological 
innovations, as evidenced by its OFAB and BioAWARE initiatives mentioned elsewhere 
(see www.ofabafrica.org and Kingiri, 2011). This notwithstanding, the biosafety policy 
brokerage role in itself is a means to achieving its ultimate technology development goal 
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and may create some tensions linked to conflict between clients agenda (farmers and 
funding organisations).  
 
(iii) African Biotechnology Stakeholders Forum (ABSF) 
ABSF (www.absfafrica.org) was founded in 2000 as a nongovernmental organisation 
with a regional focus targeting the Africa region. It is based in Kenya and hence many of 
its activities have been localised to Kenya. It works closely with ISAAA and other 
regional organisations such as AATF and national research and academic institutes. 
ABSF's mission is to create an innovative and enabling biotechnology environment in 
Africa through education, enhanced understanding and awareness creation on all aspects 
of biotechnology, biosafety and intellectual property rights (ABSF, 2010). Its major 
programme areas are: capacity building in biotechnology, and public awareness and 
participation. It has been involved in creating awareness among policy-makers and policy 
analysts of the role of biotechnology in development. Its specific activities include 
biosafety policy and advocacy work, and engaging with biotechnology development 
projects by partnering with other organisations — for example, Biotechnology Trust 
Africa (previously Kenya Agricultural Biotechnology Platform, KABP) — and local 
universities. Also, it facilitates communication, improving the public understanding, 
supporting policy development, creating capacity for information generation and 
dissemination on biotechnology and related issues. 
 
ABSF — even if it has not declared this openly in its mission statement — endeavors 
(albeit indirectly) to influence biotechnology policies and implementation. It has done 
this through conducting biotechnology awareness and training sessions for members of 
the Kenyan parliament, government officials involved in legislating and regulating 
biotechnology activities, journalists and other media actors. Just like ISAAA, ABSF’s 
ultimate goal is oriented towards pro-trade biotechnology policies. This is based on the 
conviction that biotechnology can reduce social challenges affecting the poor in Africa.  
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ABSF is strategically placed to influence policy and institutional change because it is 
managed by influential scientists who have political connections with the current 
coalition government system. In addition, a majority of its members are also practising 
scientists at Kenyan universities, where they conduct research, teach and supervise 
students. For a while now ABSF has been a member of the government decision-making 
organ, the National Biosafety Committee (NBC), now the National Biosafety Authority 
(NBA). It has also been associated with a number of pro-biotechnology organizations, 
such as USAID and Monsanto, who have supported its activities in numerous ways. 
Because of these relative advantages, ABSF was a key actor in the development of 
Kenya’s biosafety law, where it played a role of lobbying and advocacy (personal 
communication with a staff member of a donor agency, 2008).  
 
It receives funding from the Rockefeller Foundation and, previously, from UNEP-GEF 
for biosafety and biotechnology policy advocacy. It also receives funding from USAID 
and Monsanto for advocacy and lobbying work. This may create tensions linked to 
impartiality and neutrality issues as well issues over credibility of ABSF as an honest 
broker.  
 
(iv) Kenya Biodiversity Coalition (KBioC) 
This is a coalition of over 70 members (as of November 2010). Most members are 
nongovernmental organisations (NGOs) within the civil society arena, farmer 
associations and consumer associations. This coalition was previously known as the 
Kenya GMO COncern Group (KEGCO), comprising 12 members (as of September 
2004). KEGCO was formed in 2004 as a coalition of NGOs to campaign against the 
research, development and commercialisation of genetically modified products in Kenya. 
It is important to note that some of the NGOs that make up KBioC are themselves 
coalitions of other NGOs. The secretariat to this coalition is the powerful Kenya 
Federation of Farmers and Producers (KENFAP), previously the Kenya National Farmers 
Union (KNFU), with representatives from all over Kenya. On matters of biosafety, the 
coalition has, on a number of occasions, been represented by another powerful 
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organisation, the Consumer International Network (CIN). During the development of the 
biotechnology policy in Kenya, this coalition was financed and technically supported by 
Action Aid International. Even after the enactment of the Biosafety Act — that it 
proactively lobbied against (see media reports, Action Aid, 2004) — the coalition has 
continued to front the concerns of the public through the media on matters of GMOs 
(numerous media reports are available to support this).  
 
Biotechnology and related issues are not the primary objectives of KEGCO/KBioC, since 
the constituent members have got other activities commensurate with their core 
objectives. They are, however, brought together by their conviction to protect Kenya’s 
biodiversity. They perceive unregulated biotechnology to be a threat to agriculture and 
the environment and are particularly concerned with the public participation aspects of 
regulation (personal communication with a staff from a civil society NGO, October 
2010). They are involved in biosafety work, primarily that of advocacy, education, 
awareness creation, and lobbying against legislation that does not promote biological 
safety. They lobby the government as opposed to particular biotechnology organisations 
and projects. However, when lobbying the government, they take cognisance of hidden 
interests pursued by particular biotechnology projects, multinationals and funding bodies. 
It is important to note that a key role this organisation plays is that of public education, 
albeit from motives of activism and sometimes without sound scientific basis.   
 
Most members of KBioC frame their focus as being around issues of environmental and 
community safety, sustainable agriculture, food security and sustainable livelihoods. 
With regard to biotechnology, the key agenda of KBioC has been lobbying for 
responsible deployment of biotechnology products, taking into consideration the views of 
the majority — the non-scientific communities. One particular member of this coalition 
(Kenya Organic Agriculture Network, KOAN), however, advocates for GMO- free zones 
to protect the interests of organic farmers. This means they are often at loggerheads with 
pro-biotechnology players, who perceive KBioC members as anti-biotech activists 
(personal communication with a number of scientists in pro-biotech NGOs and the 
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academic arena). As much as both groups agree on responsible science, they disagree on 
the strategies that should be employed to achieve a balance between science and 
biological safety.    
 
KBioC works closely with farmers and community-based organisations. It is also able to 
consolidate finances to achieve their collective agenda, public awareness, education, 
advocacy and lobbying. This is in addition to its ability to attract funding from financing 
agencies who agree with its views, thus supporting its advocacy work. Action Aid is 
known to have been a supporter of KBioC on matters to do with biotechnology 
legislation policies (Action Aid, 2004). These connections present this coalition as a 
strong advocate of policy, institutional and social change within government and local 
communities. The fact that it is not affiliated to the government in any way removes the 
organisational and institutional barriers that may hinder it from acting proactively.  There 
is, however, a danger of neutrality and independence, considering that the funding 
agencies linked to this coalition includes environmental lobbyists who are sometimes 
known to fight biotechnology development in Africa (personal communication, 2007). It 
is also unclear whether the brokerage role can be sustained outside private funding.  
 
(v) Kenya Organic Agriculture Network (KOAN)  
There has been an organised organic farming network in Kenya that dates back to the 
1990s. KOAN (www.koan.co.ke), however, was established in 2004 as a national 
coordinating body for organic agriculture activities in Kenya. Its vision is to establish and 
coordinate “a vibrant organic agriculture industry that contributes to a healthy 
environment, livelihood security and responsive to a growing consumer market”. It has 
over 200 corporate members as well as individual members who, through the integrated 
network, serve over 50,000 people (KOAN, 2010). The organisation has a technical 
secretariat that oversees the implementation of its objectives in collaboration with its 
local and international partners and networks.  
 
  
 
 
30
KOAN is engaged in a number of activities that include: developing key competencies, 
skills and strategies in the areas of organic agriculture production, marketing certification 
and standards, training extension and information, networking, policy and advocacy. 
According to its strategic plan, KOAN aims to continue with these activities, but with the 
major aim of ensuring that the organic sub-sector increases incomes among small-scale 
producers through sustainable land use and improved marketing.  
 
One activity that KOAN has passionately pursued under the remit of policy, lobbying and 
advocacy on behalf of organic growers is that of resisting introduction of biotechnology. 
One reason for pursuing this activity is food safety concerns and possible interference in 
organic farming and marketing through GMO contamination.  
 
The main agenda of KOAN is healthy living and sustainable agriculture, while re-
orienting farmer practices towards agribusinesses around organic farming (KOAN, 
2010). Its activities are orientated toward special sustainable policies that encompass 
environmental and social livelihood issues. KOAN has been influencing agricultural 
policies in various ways. Organic agriculture is now regarded as a strategy that offers a 
wide range of environmental (biodiversity, soil fertility, etc.), social and economic 
benefits to communities, contributing to poverty reduction and sustainable development 
(IAASTD, 2009). In recognition of this, the ministry of agriculture works closely with 
KOAN and organic growers. This has contributed to key notable policy milestones: the 
national soil fertility policy contains an elaborate section on organic farming (concerning 
organic sources of soil nutrients and the value of organic fertilisers in rehabilitating 
heavily degraded soils); the food and nutritional draft policy paper also acknowledges the 
role of organic produce in food and nutritional endeavours.  
 
With regards to food safety concerns linked to GMOs, KOAN has partnered with other 
players under the KBioC coalition to lobby the government against GMO policies out of 
concerns for the public in Kenya. Due to the strategies adopted by the coalition to lobby 
the government — mainly through mass media and public demonstrations — the public 
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is now aware of GMOs, albeit from a non-balanced perspective. Members of this 
coalition, including KOAN, also receive widespread support from several politicians, 
especially on matters of GMO policies (Karembu et al., 2010, pp. 35-36) and due to its 
established connections with rural farming communities. The challenge for KOAN as a 
policy broker is the sustainability of the momentum of activities, considering that the 
government has declared biotechnology as one of the tools for development (RoK, 2006). 
If public stakeholders are to support the agenda of KOAN as a broker, then a trade-off 
has to be negotiated for balance to be achieved.  
 
(vi) Real IPM  
Real IPM (www.realipm.com) is a private company set up in Kenya in 2004, with 
operations in East Africa, Ethiopia and Ghana to promote integrated pest management 
(IPM) practices. It is linked to Dudutech Limited, a subsidiary of Homegrown 
horticultural company, and was set up to respond to the growing pesticides regulatory 
demands imposed on horticultural exports to Europe. Consequently, it pioneered the 
commercial production of bio-pesticides, initially targeting horticultural farmers, but it 
has expanded its clientele base to include small-scale farmers. Its research has generated 
regional and international interests (Biosight, 2009). The company’s mission is to provide 
horticultural production companies with the technology and training required to reduce 
reliance on pesticides and fulfill customer expectations in Good Agricultural Practice. It 
has received support from the Research Into Use (RIU) programme to promote the 
production of a mycoherbicide to control the parasitic weed striga and promote seed 
priming. The focus on small-scale farmers and a cumbersome weed re-orients Real IPM’s 
agenda towards a production problem that has affected poor farmers for many decades.  
 
In the process of registering products for commercial application Real IPM has 
encountered major regulatory hurdles. As a consequence of this, Real IPM has been 
pursuing policy brokering activities and agendas that include engaging with the 
government and scientists in registration, marketing and use of biopesticides. Previously, 
Kenya’s legislation for agricultural inputs did not include biopesticides — a gap that 
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became apparent when Dudutech applied to the regulatory agencies for importation 
approval. This triggered a series of activities that include capacity building of regulatory 
officials through exposure to regulatory systems of other countries (personal 
communication, entrepreneur, 2011). This caused the Kenya Standing Committee for 
Export and Imports (KSTCIE) — made up of different organisations in the agricultural 
sector under the Ministry of Agriculture and KEPHIS secretariat — to consider reviewing 
existing laws to address the identified regulatory vacuum. Consequently, Real IPM’s 
working relationship with players in the regulatory chain has evolved over the years.  
 
Through its longstanding experience in securing registration of biological products with 
Kenya’s regulatory agencies — Pesticides Control Products Board (PCPB) and Kenya 
Plant Health Inspectorate Service (KEPHIS) — Real IPM has been in a position to 
influence changes in regulatory policy processes. It brokered relationships leading to a 
review of import regulations and consequent drafting of Kenya’s regulations for 
biological inputs in 2003. These relationships include between research and academic 
institutes undertaking the pre-registration efficacy trials, regulatory agencies under the 
ministry of agriculture (PCPB and KEPHIS), key policy actors in the ministry of 
agriculture, the network of actors in the rural farming system (including provincial 
administration, extension workers and farmer groups). It has also been able to provide 
guidance on what sorts of approaches work and what sort of regulatory capacity needs to 
be built for the biopesticide sub-sector to flourish.  
 
Despite its larger goals of pursuing the interests of poor farming communities, Real IPM 
is profit-driven and expects to reap benefits in the short-run. There is a danger that if this 
is not realised it may need to shift its focus to other initiatives that have fewer regulatory 
hurdles. In addition, the issues of impartiality are likely to emerge during information 
dissemination and training activities.  
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(vii) Army worm control consortium 
This consortium comprises researchers, NGOs and government ministries and 
departments that have come together to find ways of controlling the migratory African 
armyworm pest. Its aim is to oversee implementation of community-based armyworm 
prediction or forecasting, and ultimately production and marketing of a simple low-cost 
and environmentally-safe biopesticides. These two initiatives are funded by RIU due to 
the economic importance of tackling armyworm in the Kenya and Tanzania agricultural 
systems.  
 
Forecasting focuses on a pheromone that is meant to attract female moths. Based on the 
outcome of the forecasting, control of the armyworm is done through the use of a bio-
control agent that is marketed by private firms. The pheromone and the biopesticide 
require registration by the respective government agencies. This has slowed the 
translation of armyworm control technologies to the poor. The consortium is led by a not-
for-profit science-based development and information organisation, CAB international 
(CABI), which is, therefore, engaged in various policy brokering activities to enhance a 
speedy registration process. CABI (http://www.cabi.org) has been able to persuade 
respective governments to support this initiative while securing their political and policy 
support. A number of significant achievements have been recorded. Firstly, the 
consortium has been brokering relationships with key players in the armyworm value 
chain. Secondly, the involvement of business-focused private actors has contributed to 
the mobilisation of the public sector to develop protocols for registration of biocontrol 
agents in Kenya. Consequently, a draft regulatory document for pheromones has been 
drafted and is being discussed by stakeholders. These developments have actually 
revolutionalised how policy-makers think, operate and act to support promising 
innovations (Africanpress, 2010; RIU press release, 2010). Thirdly, the public arm linked 
to the biopesticides sub-sector has been strengthened through capacity building. The 
actors who have benefited include extension officers and the entire regulatory arm of the 
government, as well as farmers.  
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The consortium has, within a short period of time, created requisite innovation capacity 
to effect significant policy change in Kenya’s ministry of agriculture. As a result senior 
officials have promised to fast-track the hitherto tedious registration process, while 
ensuring clarity and efficiency. They have also indicated that there is a possibility of 
waiving registration costs, initially borne by entrepreneurs. This suggests that such a 
consortium has what it takes to influence requisite institutional change for technological 
milestones to be recorded. There is, however, the danger of private sector members 
taking the lead in the brokering role, which may be seen as an invasion of government 
mandates. In addition, it is uncertain whether the private sector can be impartial in its 
undertakings, particularly where business is the motivating factor.  
 
(viii) National Biosafety Authority (NBA) 
Kenya’s NBA is a regulatory body formed under the provisions of the Biosafety Act, 
2009 (RoK, 2009). Although the Act was instituted by the president in February 2009, it 
was not till June 2010 that the NBA Board was launched. NBA is constituted of 
individual members appointed by the Minister for Higher Education, Science and 
Technology, and representatives of key regulatory agencies and government departments. 
Previously the NBA’s work was undertaken by an ad-hoc National Biosafety Committee 
(NBC) that periodically brought together a wide range of stakeholders to ostensibly 
deliberate on GMO applications. The work of policy drafting was largely a responsibility 
of technical committees appointed through the NBC under the terms of the funding 
agencies such as UNEP-GEF and PBS, funded by USAID (personal communication with 
a staff member of NBA).  
 
After the launch of the NBA board, this authority became operational. According to the 
Act, the NBA is mandated to license GMO activities in Kenya, following well spelt out 
procedures of risk assessment. This activity is still being contracted out to experts in 
academic and research institutes, perhaps because NBA is still in the process of 
establishing itself. Public awareness and education is now provided for under the Act, but 
it is still too early to speculate how this activity will be implemented. Previously, this 
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activity was left mainly to pro-biotechnology NGOs who masquerade as funding 
agencies, government partners in biotechnology, policy-makers, policy brokers, experts 
in biotechnology and biosafety, etc. Biosafety generation and dissemination is poised to 
be achieved through the Biosafety Clearing House. NBA is yet to operationalise this 
information portal.  
 
The overall agenda of NBA relates to responsible transfer of GMOs, promoting a dual 
role of technology generation and safety. Orientation is basically social and 
environmental based on this broad government mandate. Thus, NBA may be perceived to 
be spearheading regulatory policies for public interests. Whether this is the case is 
debatable. The structure of NBA and its legal mandate situates it in a position to 
influence policy. However, from the experience of Kenya’s biosafety policy-making, it is 
clear that NBA, though a government agency, cannot on its own influence policy change. 
It requires support from the public and the research/academic fraternity. 
 
NBA has received funding previously from UNEP-GEF, the Sweden-funded Eastern 
African Regional Programme and Research Network for Biotechnology, Biosafety and 
Biotechnology Policy Development (BIOEARN), African Biosafety Network Expertise 
(ABNE) of NEPAD and the USAID-funded PBS. PBS is still funding the regulations 
implementation component of biosafety capacity building, while ABNE continues to 
support human regulatory capacity building.  
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Table 1. Classification of Organisations Involved in Biosciences Regulation and Indicators of Policy Influence 
Organ  Type  Policy brokerage roles/activities  Agenda/focus  Potential to  influence regulatory 
process  
Challenges 
NBA Government 
regulatory  and 
policy agency on 
biotechnology 
and  biosafety 
matters  
‐‐Undertaking  innovation  management 
tasks as a primary role 
‐Oversight  of  the  biosafety  system, 
including  approval  of  GM  applications, 
coordination  of  regulatory  agencies  that 
enforce  the  regulations,  advising  the 
government on biotechnology & biosafety 
matters  through  the  Ministry  of  Higher 
Education,  Science  and  Technology, 
develop biosafety implementation policies 
‐Establishing a framework for 
implementation  of  the 
Biosafety Act 
‐Implementing  the  dual  role 
of  the  Kenya  government 
(biotechnology  transfer  and 
safeguarding  the  health  & 
environment)  
‐Impartiality  in  the  demand 
articulation  and  network  brokerage 
process  
‐Legal  backing  with  mandate  for 
repository  of  biosafety  information, 
public  education  and  other  capacity 
building activities 
‐Brings  a  wide  range  of  players 
together  
‐Require public and political support 
 
‐Inadequate  capacity  that  leads  to 
the masking of policy brokerage  role 
by private actors  
‐Pressure from researchers and other 
technology developers interested in a 
quick  research  and  development 
process  
‐Some demand articulation  roles are 
unaccountably  confounded  by 
government  bureaucratic 
administrative procedures 
‐Competition  over  some  policy 
management  process  tasks  with 
other knowledge brokers  
 
ISAAA  International 
NGO 
‐Brokerage  of  corporate  technologies  as 
an intermediary organisation  
‐Biotechnology  advocacy  and  public 
awareness 
‐Performing  a  liaison  function  through 
brokering  information  and  knowledge 
flow between public and private actors  
‐Capacity  building  at  both  supply  and 
demand  sides  for  cooperation  in 
biotechnology development  
 
‐Promoting  biotechnologies 
and trade  
‐Influencing  the  regulatory 
environment  for  biotech 
research and trade  
‐Established  network  of  technology 
developers,  users,  and  researchers 
and  scientists  in  both  academic  and 
policy arenas  
‐Potential  to  forge  technological and 
policy alliances  
‐Well funded strategies   
‐Obligation  to  donors  raising 
impartiality tensions 
‐‐Competition  over  some  policy 
management  process  tasks  and 
funding  sources  with  other 
knowledge brokers  
 
ABSF Regional NGO  ‐Brokering  knowledge  flows through 
biotechnology  public  awareness  and 
education activities    
‐As  a  scientists  lobby 
network,  it seeks to promote 
biotechnology  uptake 
through  information 
dissemination 
‐Focus  on  academics  and  policy‐
makers,  including  media,  as  policy 
agents  
 
‐Competition  over  some  policy 
management  process  tasks  and 
funding  sources  with  other 
knowledge brokers  
‐Obligation  to  donors  raising 
impartiality issues 
‐Adequate and sustained funds 
AATF  Regional NGO  ‐Brokering  acquisition  of  intellectual 
properties  through negotiation of  licence 
agreements  on  behalf  of  farmers  and 
researchers,  thus  making  it  possible  for 
‐Create  an  enabling 
environment  for  trade  in 
biotechnologies  (intellectual 
property rights) 
‐Established  network  of  technology 
developers,  users,  and  researchers 
and  scientists  in  both  academic  and 
policy arenas  
‐‐Obligation  to  donors  raising 
impartiality issues 
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them  to  use  proprietary  technology 
without  paying  royalties.  Acts  as 
intermediary  “honest  broker”  between 
technology developers and farmers 
‐Brokering  knowledge  flow  through 
biotechnology  public  awareness  and 
education activities    
‐Biotechnology stewardship   ‐Well funded strategies  
KBioC Local  NGO 
association  
‐Warns  against  adoption  of  GMOs  on 
account  of  threats  to  environment  and 
biodiversity,  hidden  risks  such  as 
monopolisation  of  seeds  by  large 
companies 
‐Lobbies  government  for  restrictive 
regulations  and  safeguards  against 
uncontrolled trade in GMOs  
‐Educates  public  on  negative  aspects  of 
GMOs,  citing  unbalanced  and  biased 
education by scientists   
Public  policies  that  take 
cognisance of public interests 
and concerns  
‐Message  to  public  comprises
warnings  of  threats  to  biodiversity, 
potential  monopolisation  by 
multinational  companies  among 
others 
‐Commands a wide following  
‐Engages  in  pro‐active  strategies  to 
attract political support  
‐Obligation  to  donors  raising 
impartiality issues 
KOAN National  local 
NGO  &  farmer 
organisation 
‐Lobbying against GMOs  citing  the  threat 
to agriculture  
‐Advocacy and public awareness  
‐Farmer  network  broker 
facilitating  sustainable 
agricultural  practices,  hence 
against GMOs production  
‐Message  to  public  comprises
warnings  of  threats  to  biodiversity, 
potential  monopolisation  by 
multinational  companies  among 
others  
‐Seen as a  threat to new biosciences 
development  
‐Conflicting government policies (pro‐
biotechnology)  and  pro‐diversity 
protection  
Real 
IPM 
Regional  private 
company  with 
international 
orientation 
‐Reinvigorating  the  agricultural  sector 
through  promotion  of  IPM  practices  as 
environmentally  feasible  options; 
generating  regulatory  relevant  data  for 
policy decisions  
  
‐Hybrid  development  and 
commercial  entrepreneurs 
with  social  and 
environmental orientations  
‐Established  interaction  & 
relationship  with  policy  actors, 
researchers,  and  horticultural 
growers  network;  links  with 
government agencies  in  the Ministry 
of Agriculture 
‐Impartiality in demand articulation.  
‐Popularity  of  products  in  terms  of 
social and environmental concerns  
‐Bureaucracies  within  the 
government  agencies  that  slows  the 
development process   
Army 
worm 
consor
tium 
An ad‐hoc group 
of  interested 
partners  in 
development 
and  business 
sectors  
Advocacy  and  lobbying  the  government 
and  regulators  for  regulatory  policy 
change,  brokering  relationships  in  the 
biopesticides  sector  value  chain,  training 
players in various capacities for delivery of 
the technology and policy change  
‐Development  and 
commercially‐oriented  with 
community‐based approach  
‐The  capacity  to  mobilise  the  key 
policy  actors  situates  it  in a position 
to influence policy change at another 
level  
‐Uncertainty  of  the  lead  agencies  to 
remain  impartial.  Competition  with 
the public arms of government  
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Table 2. Function‐Based Typology of Intermediary Organisations as Policy Brokers 
Type Tasks  Features Pros Cons Example 
Embedded 
brokering: 3rd 
party 
technology 
agencies 
Network formation, visionary, 
regulatory capacity building, 
communication and information 
dissemination, advocacy and lobbying 
for policy change  
Policy brokering is 
a secondary 
function intended 
to influence 
broader 
technology policy 
development; 
present 
themselves as 
neutral agencies  
‐Stimulate significant 
institutional and 
organisational 
innovations (systemic 
value) and linkages. 
‐Readily available 
resources including 
avenues to pursue 
policy actions  
 
‐Failure of clients to see the immediate 
value of intermediation owing to politics.  
‐Uncertainty of outcome of brokerage to 
steer effective reformism/policy change 
‐Undeclared or hidden vested interests 
leading to neutrality & credibility tensions, 
conflicting objectives impacting impartiality 
‐Heterogeneous functions and competition 
among knowledge brokers  
ISAAA, 
AATF, ABSF  
Embedded 
brokering: 
business & 
development 
organisations  
Advocacy for regulatory change, data 
collection to generate evidence to 
support regulatory policy and to bring 
about change in regulatory practice  
 
Economic and 
social orientation 
spurs the policy 
brokerage function 
pursued in a less 
structured way   
‐The shifting role of 
NGOs and private 
sector to spur 
significant 
institutional and 
organisational 
innovations and 
linkages (systemic 
value) 
‐Uncertainty of funding to sustain the 
policy brokerage function  
‐Uncertainty of outcome of brokerage to 
steer effective reformism/policy change  
REAL‐IPM, 
Armyworm 
consortium, 
KOAN 
Proactive 
activism  
‐Advocacy and lobbying for policy 
change, public awareness, client 
representation, information gathering 
and dissemination, regulatory policy 
capacity building 
‐Active, direct and 
confrontational 
engagement of 
clients in policy 
dialogues  
‐Prompt attention of 
policy actors; clients 
trust (pro and anti 
technology). 
‐Neutrality & credibility linked to pro and 
anti technology lobby groups. 
KBioC, KBC 
Boundary 
spanners  
Public awareness and communication, 
advisory services, creation of platforms 
for negotiation, liaison and mediation, 
steering and coordination of clients  
 
‐ Balancing of 
different interests 
through mediation  
‐Objective, neutral 
and credible   
‐Inadequate skills and competencies 
needed to span boundaries confounded by 
political bio‐economy landscape   
NBA 
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Description of the Different Types of Policy Brokers based on typology 
 
Table 2 identifies four categories of brokers, two of which are closely interrelated.  
  
A. Embedded brokering  
This typology describes a brokering function that is part of the innovation process, where 
policy brokering is embraced to achieve a certain agenda. For the cases analysed in this 
paper, two types of embedded brokers have been identified.  
 
a) Third party technology agencies: These have assumed a policy brokering role 
as part of an agenda to improve access to biosciences. As demonstrated in this 
paper, they engage in crucial secondary innovation tasks that stimulate a dynamic 
and systemic engagement that leads to useful policy change. This role is 
embedded in the overall technological development goal, which implies that the 
resources needed to drive the policy process are readily available. Perhaps not 
deliberately, these actors present themselves as neutral policy brokers. This may 
have ramifications that relate to impartiality.  
 
b) Business and development organisations: These are agencies that present 
themselves as entrepreneurs and development agencies at the same time. They 
engage in policy brokering as part of an agenda to create an enabling environment 
for business and social development in agri-based innovations. Because of their 
business orientation, neutrality tensions may arise as well as challenges in 
sustaining the policy brokerage function to a point where significant policy 
change is experienced.  
 
 
B. Proactive activism 
This typology describes agencies that engage in intense advocacy and lobbying to pursue 
a pre-determined policy perspective. They command authority from their positions at 
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junctures of networks enabling intense learning and diffusion of different knowledge 
claims. In addition, they command clients’ attention and trust that augment the dynamism 
involved. These factors are potentially enough to cause a prompt and significant 
institutional and policy change. However, the ensuing intense lobbying and advocacy 
may be detrimental to innovation, especially in cases of uncertainty and politics (see 
Kingiri, 2011; Herring, 2010). This may affect impartiality, bringing about protracted 
tension that may further delay the innovation process.  
 
C. Boundary spanners 
This typology is characterised by the mediation, communication and coordination tasks to 
bring about consensus amongst clients situated at different sides of policy boundaries. 
The boundaries may be brought about by differences in agenda being pursued or different 
opinions around how policy should be pursued like in the case of biosciences. Boundary 
spanners, thus, provide a forum for discussion and negotiation, and are accountable to 
groups on both sides of the boundary. Although the one case considered in this paper is 
not conclusive enough to describe this typology, boundary spanners command trust from 
clients on both sides due to the expected non-biased approach to negotiation (Kristjanson 
et al., 2009). This may enhance credibility while minimising chances of tensions linked to 
neutrality. One main challenge that boundary spanners may encounter relates to the high-
level skills and competencies needed to perform this role. 
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6. DISCUSSION  
 
 
As shown in Tables 1 and 2, the analysis of the cases has revealed four broad categories 
of policy brokers in Kenya’s biosciences knowledge infrastructure. One key characteristic 
cutting across the four categories is the articulation of policy brokerage as a secondary 
function to achieve a larger aim. The two distinct embedded brokerage categories expose 
a policy brokerage function that is heavily integrated into overall routine activities. The 
cases falling under these categories have primarily a broad-based focus, expanding their 
functions to facilitate regulatory policy processes. ISAAA, AATF and ABSF, for 
instance, pursue policy brokerage in order to enable biotechnology access and use and 
thus remain technology-focused in their approach as third party technology agencies. 
Business and development organisations like Real IPM and the Army worm consortium 
engage in policy brokering as a means to pursuing their social and economic endeavors as 
entrepreneurs. Arguably, their starting point is farmers’ access to technology, initially 
structuring their activities around bringing the right players together. Along the way 
regulatory hurdles impede their developmental goal, which prompts them to lobby 
support from influential partners in public arena. These types of brokers are emerging in 
an unprecedented way, causing significant disruptions in the agricultural sub-sectors (see 
Hall et al., 2010). KOAN is a different type of special apex organisation that has taken up 
the policy brokering role as an embedded advocacy function on behalf of inadequately 
placed members, mainly smallscale farmer groups engaged in organic farming as a 
business enterprise. KBioC and KBC demonstrate how proactive activism can spur policy 
change through advocacy and direct lobbying for clients’ engagement in policy 
dialogues. Because they tend to identify with particular needs of clients, they generate 
relative trust and credibility.  
 
The four categories of brokers discussed here attract different challenges in articulation of 
the policy brokerage function. These include neutrality and competition issues made 
worse by the political nature of new biosciences, particularly biotechnology. The features 
of the proactive activism typology, for instance, reinforce the political nature of the new 
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biosciences knowledge infrastructure, as has been debated by governance scholars (Tait 
et al., 2006; Herring, 2010). The analysis presented in this paper, however, goes beyond 
the embedded governance rhetoric and opens up new thinking around how intermediary 
organisations can function as policy brokers for positive influence through proactive 
activism. Thus, productive policy brokerage calls for some sort of “boundary spanning” 
effectively performed by a boundary spanner. Of all the cases analysed in this paper, 
NBA is the only one that qualifies as a boundary spanner. Arguably, as the analysis 
suggests, in the Kenyan context a public organisation is best suited to mediate between 
the different interests of different clients and the controversies this generates. It thus 
serves as a credible and neutral platform where impartiality may be pursued towards 
attaining a balance of views. The boundary spanning role in agricultural development has 
been identified as a way of linking knowledge with action through creating and sustaining 
relationships, building trust, communicating information needs and bridging gaps 
between various stakeholder groups (Kristjanson et al., 2009). Boundary organisations 
have also been popularised in science policy debates, mediating between science and the 
public in controversial policy arenas (Jasanoff, 1990 and regulation of biotechnology in 
the US). Jasanoff (1990) notes that this form of brokerage may be hampered by 
credibility tensions — considering that the policy process in controversial 
biotechnologies is value-based. This notwithstanding, boundary spanners play a critical 
role in bringing about social order in knowledge brokering (Guston, 2001).  
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7. CONCLUSIONS AND IMPLICATIONS FOR POLICY 
 
 
This paper has shown that different intermediary agencies perform policy brokerage 
roles, albeit as third party agencies, but with significant influence on regulatory policy 
needed to impact economic change in biosciences research. But what does this mean for 
public support to the policy brokering function?  
 
• There is a need to acknowledge the different tasks that entail policy brokerage and 
the fact that regulation of biosciences constitutes a wide range of these tasks (see 
Table 1 and 2). These tasks are important and require a wide range of skills, 
resources and well-orchestrated strategies (Kingiri, 2011, Kingiri, 2010). This 
does not, however, imply that the government should support a certain specialised 
agency to perform these purportedly special policy brokering tasks. It could, 
however, support an assorted collection of different organisations or initiatives 
performing different policy brokerage tasks. For instance, the government may 
consider facilitating or supporting the role of enterprise development agencies as 
policy brokers because they tend to engage in a wider set of brokerage roles 
crucial for innovation to take place (Hall, 2010; Hall et al., 2010). This is, 
however, a challenge for any government as some of these organisations embed in 
policy brokering as part of a broader objective — for example, technology or 
enterprise development. This presents further governance challenges already 
identified as problematic in some biosciences research and development.  
• Policy brokering is a pervasive and dynamic function as alluded to above, which 
brings about positive and negative impacts (see Tables 1 & 2). This is where 
policy support needs to be directed towards strengthening and harnessing the 
positive impacts where government could choose the tasks it wishes to promote. It 
might be that policy change may be achieved by packaging together the tasks 
performed by different organisations, backed by embedded strengths and skills.  
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• The governance challenges relating to neutrality and impartiality issues need to be 
addressed and this is where the government must invest in counter activities. The 
role of boundary spanners ought to be that of providing checks and balances to 
counter neutrality while tapping into the resources that these brokering agencies 
contribute to the policy brokering function. The boundary spanners could also 
orchestrate the tasks performed by the proactive activists that would ensure that 
the activism is controlled and confined within the respective boundaries. 
Eventually this translates to productive activism.  
 
The purpose of the typology developed in this paper is draw attention to the different 
agencies and initiatives emerging to play different sorts of policy brokerage roles. It also 
brings to the limelight the pros and cons of each category of policy broker described. 
Consequently, policy-makers can make informed decisions regarding what agencies 
and/or tasks to support, and the likely implications for putting biosciences research to 
use. Policy-makers need to harness the opportunities presented by these intermediary 
agencies in order to stimulate positive policy change that will impact biosciences 
development and innovation. This implies that the policy brokerage function needs to be 
given critical thought during the start-up and development of biosciences innovations in 
order for this to be integrated into the strategic objectives upfront. Consequently, this is 
likely to impact a systemic value to the development of the sub-sector and the 
agricultural sector as a whole. 
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